|OncoSec Medical Incorporated|
9810 Summers Ridge Road
United States - Map
OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States. The company is developing technology based on the proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Its clinical programs include three Phase II clinical trials to assess the cancer-destroying and tissue-sparing properties of the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. The company was formerly known as NetVentory Solutions, Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
|Dr. Avtar Dhillon M.D.,
Co-Founder, Chairman, Chairman of Financing Committee, Chairman of Compensation Committee, Member of Nominating & Corp. Governance Committee, Member of Clinical & Regulatory Affairs Committee and Member of Audit Committee
|Mr. Punit S. Dhillon ,
Co-Founder, Chief Exec. Officer, Pres and Director
|Ms. Veronica Vallejo CPA,
Chief Financial Officer, Principal Accounting Officer and VP of Fin.
|Mr. Richard McKilligan ,
Corp. Legal Counsel
|Dr. Adil I. Daud M.D.,
Chief Clinical Strategist, Chairman of Melanoma Advisory Board and Member of Clinical & Scientific Advisory Board
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|